1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one

ID: ALA5208874

PubChem CID: 168294393

Max Phase: Preclinical

Molecular Formula: C12H11FN4O4S

Molecular Weight: 326.31

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCN(c2nnc(-c3ccc(F)cc3)o2)C1=O

Standard InChI:  InChI=1S/C12H11FN4O4S/c1-22(19,20)17-7-6-16(12(17)18)11-15-14-10(21-11)8-2-4-9(13)5-3-8/h2-5H,6-7H2,1H3

Standard InChI Key:  UWPSHDHGUSROMV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.2687   -0.4388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9362    0.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6812    0.8308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1438    0.8308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3986    0.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1958   -0.1674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8368    0.3514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5287   -0.0976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3151   -0.8944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4913   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7333   -0.1674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9472   -0.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7421   -1.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3259   -0.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1148    0.2003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3193    0.4184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8368    1.1768    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3258    0.1159    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5394    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5398   -0.6826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1229   -0.0976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1229   -0.8067    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 11  2  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 11 16  1  0
 16 15  2  0
  7 17  2  0
  8 18  1  0
 18 19  1  0
 18 20  2  0
 18 21  2  0
 14 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5208874

    ---

Associated Targets(non-human)

Aedes aegypti (630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 326.31Molecular Weight (Monoisotopic): 326.0485AlogP: 1.08#Rotatable Bonds: 3
Polar Surface Area: 96.61Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 0.11CX LogD: 0.11
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.84Np Likeness Score: -1.79

References

1. De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK..  (2022)  Seeking heterocyclic scaffolds as antivirals against dengue virus.,  240  [PMID:35816877] [10.1016/j.ejmech.2022.114576]

Source